Given that activation of the WNK-SPAK/OSR1 pathway produces antagonistic effects on KCC2 and NKCC1, it remains to be determined whether the phosphorylation status of either KCC2 and/or NKCC1 are impacted in HD. Here, SLC12A2 is linked to Huntington disease.